linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Solara Active Pharma Sciences Ltd.
 
Source DateBoard Meeting DateDetails
08 May 202615 May 2026 Audited Results
19 Mar 202624 Mar 2026 Inter alia, to consider and approve :- a) To consider making Second and Final Call on partly paid-up Equity Shares issued by the Company on rights basis in accordance with the Letter of Offer dated May 09, 2024. b) To fix the Record Date for the purpose of determining the eligible shareholders for payment of the said call money. c) Any other matters, which may be incidental and ancillary to making aforesaid Second and Final call.
30 Jan 202606 Feb 2026 Quarterly Results
29 Oct 202505 Nov 2025 Quarterly Results
18 Jul 202525 Jul 2025 Quarterly Results
07 May 202515 May 2025 Audited Results
26 Mar 202502 Apr 2025 Inter-alia, to consider and approve:- (1) the First Call money Notice, on the partly paid Equity Shares issued on Rights basis which is to be sent to the eligible Shareholders
20 Mar 202526 Mar 2025 Inter alia, to consider and approve :- a) To consider and approve, a proposal of making First Call on 1,19,98,755 partly paid-up Equity Shares, having a face value of Rs.10/- each (Rs.3.50/- paid-up) issued by the Company on rights basis in accordance with the Letter of Offer dated May 09, 2024. b) Any other matters, which may be incidental and ancillary to making aforesaid first call.
16 Jan 202524 Jan 2025 Quarterly Results
14 Oct 202421 Oct 2024 Quarterly Results
15 Jul 202422 Jul 2024 Quarterly Results
21 May 202429 May 2024 Audited Results
05 Feb 202414 Feb 2024 Quarterly Results
08 Nov 202314 Nov 2023 Quarterly Results
07 Aug 202314 Aug 2023 Quarterly Results (Revised)
04 Aug 202311 Aug 2023 Quarterly Results
30 Jun 202305 Jul 2023 Right Issue of Equity Shares
04 May 202312 May 2023 Audited Results
19 Jan 202325 Jan 2023 Quarterly Results
02 Nov 202209 Nov 2022 Quarterly Results
Page 1 of 2
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.